No Data
No Data
Tonix Pharmaceuticals Stock Tumbles on Earnings Miss
Tonix Pharmaceuticals Reports Q4 EPS ($9.77) Vs. ($2,179.83) Last Year
Tonix Pharmaceuticals | 10-K: Annual report
Express News | Tonix Pharmaceuticals: Anticipated Q4 2025 Launch of Tnx-102 Sl for Fibromyalgia
Express News | Tonix Pharmaceuticals: Expects to Have Sufficient Cash to Fund Planned Operations Beyond FDA Pdufa Goal Date
Tonix Pharmaceuticals 4Q Loss/Shr $9.77 >TNXP